Inventor · Doylestown, PA, US

Kathrin Ute Jansen

74Patents
15h-index
87Co-inventors
87Inventor score

Filing activity: Mar 22, 1995 → Jul 15, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9492559B2 Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof Emerging Cross-Sectional Technologies 36 Active
US6159729A Synthetic HPV6/11 hybrid L1 DNA encoding human papillomavirus type 11 L1 protein Chemistry; Metallurgy 32 Expired
US5840306A DNA encoding human papillomavirus type 18 Emerging Cross-Sectional Technologies 29 Expired
US8986710B2 Neisseria meningitidis compositions and methods thereof Human Necessities 26 Active
US8481692B2 Compositions relating to a mutant Clostridium difficile toxin and methods thereof Chemistry; Metallurgy 22 Active
US6290965A DNA encoding human papillomavirus type 6A Chemistry; Metallurgy 22 Expired
US8557548B2 Compositions relating to a mutant Clostridium difficile toxin and methods thereof Chemistry; Metallurgy 19 Active
US9724402B2 Neisseria meningitidis composition and methods thereof Human Necessities 18 Active
US9561269B2 Neisseria meningitidis compositions and methods thereof Human Necessities 18 Active
US7001995B1 Synthetic human papillomavirus genes Chemistry; Metallurgy 17 Expired
US6991795B1 Protein delivery system using human papillomavirus virus-like particles Chemistry; Metallurgy 17 Expired
US5821087A Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA Emerging Cross-Sectional Technologies 16 Expired
US9822150B2 Neisseria meningitidis compositions and methods thereof Emerging Cross-Sectional Technologies 16 Active
US9802987B2 Immunogenic fusion polypeptides Chemistry; Metallurgy 16 Active
US9757443B2 Non-lipidated variants of Neisseria meningitidis ORF2086 antigens Emerging Cross-Sectional Technologies 16 Active
US10226525B2 Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof Emerging Cross-Sectional Technologies 13 Active
US5820870A Recombinant human papillomavirus type 18 vaccine Emerging Cross-Sectional Technologies 12 Expired
US7211569B2 Synthetic human papilloma virus genes Chemistry; Metallurgy 12 Expired
US10512681B2 Non-lipidated variants of Neisseria meningitidis ORF2086 antigens Emerging Cross-Sectional Technologies 11 Active
US10196429B2 Neisseria meningitidis composition and methods thereof Human Necessities 10 Active
US5888516A Recombinant papillomavirus vaccines Emerging Cross-Sectional Technologies 10 Expired
US10550159B2 Neisseria meningitidis composition and methods thereof Human Necessities 10 Active
US8900597B2 Compositions relating to a mutant Clostridium difficile toxin and methods thereof Chemistry; Metallurgy 10 Active
US8568735B2 Immunogenic compositions of Staphylococcus aureus antigens Chemistry; Metallurgy 10 Active
US9745354B2 Compositions relating to a mutant Clostridium difficile toxin and methods thereof Chemistry; Metallurgy 9 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.